Abstract
Thirty one diabetic patients were prospectively randomized for treatment with or without tranexamic acid during vitrectomy for proliferative diabetic retinopathy. No significant difference in the occurrence of postoperative haemorrhage in the treated and untreated group was observed (37%/28% during the 1st postoperative week, and 25%/40% during the 2nd–4th postoperative weeks, respectively). The final visual result was similar in both groups.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
de Bustros S, Glaser BM, Michels RG, Auer C: Effect of-aminocaproic acid on postvitrectomy hemorrhage. Arch Ophthalmol 103: 219–221, 1985
Goldberg MF: Antifibrinolytic agents in the management of traumatic hyphema. Arch Ophthalmol 101: 1029–1030, 1983
Schachat AP, Oyakawa RT, Michels RG, Rice TA: Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology 90: 522–530, 1983
Uusitalo RJ, Saari MS, Aine E, Saari KM: Tranexamic acid in the prevention of secondary haemorrhage after traumatic hyphaema. Acta Ophthalmol 59: 539–545, 1981
Vinnicombe J, Shuttleworth KED: Aminocaproic acid in the control of haemorrhage after prostatectomy: Safety of aminocaproic acid: A controlled trial. Lancet 1: 232–234, 1966
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Laatikainen, L., Summanen, P. & Immonen, I. Effect of tranexamic acid on postvitrectomy haemorrhage in diabetic patients. Int Ophthalmol 10, 153–155 (1987). https://doi.org/10.1007/BF00139341
Issue Date:
DOI: https://doi.org/10.1007/BF00139341